GZD824

Target: This ligand targets BCR-ABL/ABL1 tyrosine kinase, including resistant mutant forms in biochemical or cellular target-engagement studies.

Mechanism of Action: Used as the target-protein recognition element, this ligand provides the binding interface for BCR-ABL/ABL1 tyrosine kinase, including resistant mutant forms. In PROTAC design, a derivatizable position on the ligand can be connected through an optimized linker to an E3 ligase ligand, such as a CRBN, VHL, or IAP recruiter, while preserving productive target engagement. The resulting bifunctional molecule brings BCR-ABL/ABL1 tyrosine kinase into proximity with the recruited E3 ligase, enabling ternary-complex formation. If the complex has favorable geometry and residence time, target lysine ubiquitination is promoted, leading to proteasome-dependent degradation in experimental systems.

• PROTAC-Mediated Degradation Studies: GZD824 can be used as a targeting ligand in PROTAC designs to recruit an E3 ligase and drive selective degradation of the associated protein. Researchers can evaluate degradation potency, time dependence, and dose-response by immunoblotting or quantitative proteomics, enabling mechanism-focused optimization of linker length and attachment geometry.

• E3 Ligase Recruitment Optimization: Incorporating GZD824 into PROTAC architectures allows systematic testing of different E3 ligase binders and conjugation strategies. By comparing degradation efficiency across ligase recruiters and linker chemistries, investigators can map how ternary complex formation influences ubiquitination and proteasome-dependent turnover.

• Mechanistic Pathway Dissection: GZD824-based PROTACs can support studies of ubiquitin-proteasome dependence and pathway specificity. Using proteasome inhibitors, neddylation modulators, and competition assays, researchers can determine whether degradation proceeds via canonical ubiquitination and identify rate-limiting steps governing target engagement and chimeric complex stability.

• Target Engagement and Selectivity Profiling: PROTACs built with GZD824 enable rigorous assessment of target engagement versus off-target effects. Time-resolved degradation measurements, thermal shift or binding assays, and proteome-wide profiling can clarify whether observed loss of the target reflects productive ternary complex formation rather than non-specific cytotoxicity.

GZD824 is a ABL/Src-family kinase target ligand intended for use as the target-engaging component or reference ligand in PROTAC discovery workflows. Its known small-molecule recognition profile enables rational linker-vector evaluation and comparative degrader design. This molecule is described in detail below.

Structure: The structure of GZD824 is characterized by primary or secondary amine/basic nitrogen centers; amide/urea/sulfonamide hydrogen-bonding motifs; alkyne or click-compatible unsaturation; halogenated aryl/heteroaryl ring system. These features provide defined hydrogen-bonding, hydrophobic, and steric elements that can support affinity retention while enabling analogue-based linker-vector selection.

Reactivity: The amine/basic nitrogen-containing motif can be evaluated for acylation, sulfonylation, alkylation, or carbamate/urea linker installation when that vector is solvent exposed. For PROTAC construction, the POI ligand can be paired with CRBN ligands such as thalidomide, pomalidomide, or lenalidomide analogues, VHL ligands such as VH032 derivatives, or less common IAP/MDM2/cIAP-recruiting ligands, with alkyl, PEG, piperazine, triazole, or amide linkers screened for ternary-complex formation. In practice, incorporation into PROTACs should begin from derivatives that preserve the reported binding pharmacophore, followed by systematic variation of linker length, polarity, rigidity, and exit-vector geometry to optimize target engagement, E3 recruitment, and cellular degradation readouts.